0001144204-14-005103.txt : 20140130
0001144204-14-005103.hdr.sgml : 20140130
20140130200218
ACCESSION NUMBER: 0001144204-14-005103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140128
FILED AS OF DATE: 20140130
DATE AS OF CHANGE: 20140130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Chelsea Therapeutics International, Ltd.
CENTRAL INDEX KEY: 0001333763
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203174202
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3530 TORINGDON WAY
STREET 2: SUITE 200
CITY: CHARLOTTE
STATE: NC
ZIP: 28277
BUSINESS PHONE: 704-341-1516
MAIL ADDRESS:
STREET 1: 3530 TORINGDON WAY
STREET 2: SUITE 200
CITY: CHARLOTTE
STATE: NC
ZIP: 28277
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schmidt Keith
CENTRAL INDEX KEY: 0001389235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51462
FILM NUMBER: 14562353
MAIL ADDRESS:
STREET 1: C/O CHELSEA THERAPEUTICS, INC.
STREET 2: 13950 BALLANTYNE CORPORATE PL, UNIT 325
CITY: CHARLOTTE
STATE: NC
ZIP: 28277
4
1
v366692_4.xml
OWNERSHIP DOCUMENT
X0306
4
2014-01-28
0
0001333763
Chelsea Therapeutics International, Ltd.
CHTP
0001389235
Schmidt Keith
3530 TORINGDON WAY
SUITE 200
CHARLOTTE
NC
28277
0
1
0
0
Chief Commercial Officer
Stock Option (Right to Buy)
4.50
2014-01-28
4
A
0
100000
0
A
2024-01-28
Common Stock
100000
100000
D
Option vests in four equal annual installments beginning on January 28, 2015.
/s/ Keith W. Schmidt
2014-01-30